ARKG is trading at $36.66 (-3.00%) as biotech and genomics names face pressure from a broader rotation out of high-growth healthcare.
- The move aligns with a wider Nasdaq selloff and general weakness across AI and growth-oriented sectors.
- Market sentiment has turned risk-off ahead of the upcoming FOMC meeting, weighing heavily on innovation-focused ETFs.